Dopamine deficiency underlies learning deficits in neurofibromatosis-1 mice

Annals of Neurology

Volumn 73, Issue 2, 2013, Pages 309-315

  Diggs Andrews, Kelly A ^a   Tokuda, Kazuhiro ^a   Izumi, Yukitoshi ^a   Zorumski, Charles F ^a   Wozniak, David F ^a   Gutmann, David H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP PHOSPHODIESTERASE; DOPAMINE; LEVODOPA; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DISEASE; BRAIN ELECTROPHYSIOLOGY; CONTROLLED STUDY; DOPAMINE DEFICIENCY; HIPPOCAMPUS; LEARNING DISORDER; MOUSE; NERVE FIBER; NEUROFIBROMATOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SPATIAL LEARNING; VENTRAL TEGMENTUM;

ANIMALS; ATTENTION; CYCLIC AMP; DOPAMINE; HIPPOCAMPUS; LEARNING DISORDERS; MEMORY DISORDERS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUROFIBROMATOSIS 1; NEUROFIBROMIN 1; SIGNAL TRANSDUCTION; VENTRAL TEGMENTAL AREA;

EID: 84875412596     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.23793     Document Type: Article

References (20)

1. Mautner VF, Kluwe L, Thakker SD, Leark RA,. Treatment of ADHD in neurofibromatosis type 1. Dev Med Child Neurol 2002; 44: 164-170.
2. Hyman SL, Arthur Shores E, North KN,. Learning disabilities in children with neurofibromatosis type 1: subtypes, cognitive profile, and attention-deficit-hyperactivity disorder. Dev Med Child Neurol 2006; 48: 973-977.
3. Cui Y, Costa RM, Murphy GG, et al. Neurofibromin regulation of ERK signaling modulates GABA release and learning. Cell 2008; 135: 549-560.
4. Li W, Cui Y, Kushner SA, et al. The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1. Curr Biol 2005; 15: 1961-1967.
5. Brown JA, Emnett RJ, White CR, et al. Reduced striatal dopamine underlies the attention system dysfunction in neurofibromatosis-1 mutant mice. Hum Mol Genet 2010; 19: 4515-4528.
6. Brown JA, Xu J, Diggs-Andrews KA, et al. PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice. Exp Neurol 2011; 232: 333-338.
7. Tong J, Hannan F, Zhu Y, et al. Neurofibromin regulates G protein-stimulated adenylyl cyclase activity. Nat Neurosci 2002; 5: 95-96.
8. Brown JA, Gianino SM, Gutmann DH,. Defective cAMP generation underlies the sensitivity of CNS neurons to neurofibromatosis-1 heterozygosity. J Neurosci 2010; 30: 5579-5589.
9. Guo HF, Tong J, Hannan F, et al. A neurofibromatosis-1-regulated pathway is required for learning in Drosophila. Nature 2000; 403: 895-898.
10. Buchanan ME, Davis RL,. A distinct set of Drosophila brain neurons required for neurofibromatosis type 1-dependent learning and memory. J Neurosci 2010; 30: 10135-10143.
11. Qin H, Cressy M, Li W, et al. Gamma neurons mediate dopaminergic input during aversive olfactory memory formation in Drosophila. Curr Biol 2012; 22: 608-614.
12. Payne JM, Hyman SL, Shores EA, North KN,. Assessment of executive function and attention in children with neurofibromatosis type 1: relationships between cognitive measures and real-world behavior. Child Neuropsychol 2011; 17: 313-329.
13. Krab LC, de Goede-Bolder A, Aarsen FK, et al. Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial. JAMA 2008; 300: 287-294.
14. Guilding C, McNair K, Stone TW, Morris BJ,. Restored plasticity in a mouse model of neurofibromatosis type 1 via inhibition of hyperactive ERK and CREB. Eur J Neurosci 2007; 25: 99-105.
15. Denayer E, Ahmed T, Brems H, et al. Spred1 is required for synaptic plasticity and hippocampus-dependent learning. J Neurosci 2008; 28: 14443-14449.
16. Ho IS, Hannan F, Guo HF, et al. Distinct functional domains of neurofibromatosis type 1 regulate immediate versus long-term memory formation. J Neurosci 2007; 27: 6852-6857.
17. Hannan F, Ho I, Tong JJ, et al. Effect of neurofibromatosis type I mutations on a novel pathway for adenylyl cyclase activation requiring neurofibromin and Ras. Hum Mol Genet 2006; 15: 1087-1098.
18. Gasbarri A, Sulli A, Innocenzi R, et al. Spatial memory impairment induced by lesion of the mesohippocampal dopaminergic system in the rat. Neuroscience 1996; 74: 1037-1044.
19. El-Ghundi M, Fletcher PJ, Drago J, et al. Spatial learning deficit in dopamine D(1) receptor knockout mice. Eur J Pharmacol 1999; 383: 95-106.
20. Xing B, Kong H, Meng X, et al. Dopamine D1 but not D3 receptor is critical for spatial learning and related signaling in the hippocampus. Neuroscience 2010; 169: 1511-1519.